K. LEONARD JUDSON
Leonard is the President and Managing Director of Cycad Group. Prior to co-founding Cycad Group in 2000, he practiced law for 14 years and was a partner in two law firms. Throughout his legal career a substantial portion of his practice was devoted to representing both companies and investors in corporate finance, mergers and acquisitions. Leonard’s entrepreneurial and management skills were further enhanced when he co-founded the law firm of May, Potenza, Judson and Baran, P.C., and served as its CEO until his departure to the Cycad Group. Leveraging upon his experience interning for the SEC while in law school and his subsequent securities law practice, Leonard was as a member of the NASD Board of Arbitrators from 1989 to 2002 and chaired a number of securities industry related arbitrations.
Among his activities at Cycad Group, Leonard serves as a Director or observer to the board of directors of several of Cycad Group’s portfolio companies including, ImaginAb, Nanosteel Corporation, Sofie Biosciences, and Lixivia. Leonard has previously been a director or board observer on the boards of Genocea Biosciences (Nasdaq NM: GNCA) and Clean Diesel Technologies, Inc. (Nasdaq NM: CDTI), GRT, Inc., ZT3 Technologies and Agile RF. Leonard also serves as a Director and the CEO of the Glenn Foundation For Medical Research, Inc., a non-profit foundation supporting research to understand the biology of aging with the objective of developing interventions to extend the healthy years of human life.
Leonard holds a J.D. with Honors, from George Washington University, Washington, D.C., and a B.S. degree, Cum Laude, from Northern Arizona University.